End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.085 AUD | -2.30% | +14.86% | +44.07% |
06-03 | Percheron Therapeutics Names Chief Medical Advisor | MT |
05-29 | Percheron Therapeutics Completes Enrollment for Phase Two Muscular Dystrophy Trial; Shares Rise 3% | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+44.07% | 51.05M | |
+19.33% | 125B | |
+13.95% | 108B | |
-3.53% | 24.57B | |
+3.49% | 22.82B | |
-10.23% | 18.19B | |
-41.48% | 16.54B | |
-12.62% | 16.5B | |
+0.99% | 13.39B | |
+21.79% | 11.1B |
- Stock Market
- Equities
- PER Stock
- News Percheron Therapeutics Limited
- Antisense Therapeutics Identifies Potential Biomarkers from Long COVID-19 Study; Shares Rise 5%